FDA.reportPublic FDA data

phentermine 3.75 MG / topiramate 23 MG 24HR Extended Release Oral Capsule

RxCUI
1302839
RxNorm name
phentermine 3.75 MG / topiramate 23 MG 24HR Extended Release Oral Capsule
Display name
phentermine 3.75 MG / topiramate 23 MG 24HR Extended Release Oral Capsule
Full name
phentermine 3.75 MG / topiramate 23 MG 24HR Extended Release Oral Capsule
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:55

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 4 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
phentermine and topiramatePHENTERMINE AND TOPIRAMATEPrasco Laboratories876bd763-13fa-481e-b579-c2fc44dbf3c22026-05-18Warnings, Adverse reactionsExact identifier
rxcui: 1302839
QsymiaPHENTERMINE AND TOPIRAMATEVivus LLC40dd5602-53da-45ac-bb4b-15789aba40f92026-04-22Warnings, Adverse reactionsExact identifier
rxcui: 1302839
Phentermine and Topiramate Extended-ReleasePHENTERMINE AND TOPIRAMATE EXTENDED-RELEASEDr.Reddys Laboratories Inc260c3f90-163d-0bdd-1099-55d18a900e682026-03-31Warnings, Adverse reactionsExact identifier
rxcui: 1302839
Phentermine and topiramatePHENTERMINE AND TOPIRAMATETeva Pharmaceuticals, Inc.918df93d-e033-4419-adcc-e21655ef81582026-03-30Warnings, Adverse reactionsExact identifier
rxcui: 1302839

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
40dd5602-53da-45ac-bb4b-15789aba40f9phentermine 3.75 MG / topiramate 23 MG 24HR Extended Release Oral CapsulePSN42These highlights do not include all the information needed to use QSYMIA ® safely and effectively. See full prescribing information for QSYMIA. QSYMIA (phentermine and topiramate extended-release capsules), for oral use, CIV Initial U.S. Approval: 201220260422
40dd5602-53da-45ac-bb4b-15789aba40f924 HR phentermine 3.75 MG / topiramate 23 MG Extended Release Oral CapsuleSCD42These highlights do not include all the information needed to use QSYMIA ® safely and effectively. See full prescribing information for QSYMIA. QSYMIA (phentermine and topiramate extended-release capsules), for oral use, CIV Initial U.S. Approval: 201220260422
40dd5602-53da-45ac-bb4b-15789aba40f9phentermine 3.75 MG / topiramate 23 MG 24 HR Extended Release Oral CapsuleSY42These highlights do not include all the information needed to use QSYMIA ® safely and effectively. See full prescribing information for QSYMIA. QSYMIA (phentermine and topiramate extended-release capsules), for oral use, CIV Initial U.S. Approval: 201220260422
260c3f90-163d-0bdd-1099-55d18a900e6824 HR phentermine 3.75 MG / topiramate 23 MG Extended Release Oral CapsuleSCD9These highlights do not include all the information needed to use PHENTERMINE AND TOPIRAMATE EXTENDED-RELEASE CAPSULES, safely and effectively. See full prescribing information for PHENTERMINE AND TOPIRAMATE EXTENDED-RELEASE CAPSULES. PHENTERMINE and TOPIRAMATE extended-release capsules, for oral use, CIV Initial U.S. Approval: 201220260331
260c3f90-163d-0bdd-1099-55d18a900e68phentermine 3.75 MG / topiramate 23 MG 24 HR Extended Release Oral CapsuleSY9These highlights do not include all the information needed to use PHENTERMINE AND TOPIRAMATE EXTENDED-RELEASE CAPSULES, safely and effectively. See full prescribing information for PHENTERMINE AND TOPIRAMATE EXTENDED-RELEASE CAPSULES. PHENTERMINE and TOPIRAMATE extended-release capsules, for oral use, CIV Initial U.S. Approval: 201220260331
260c3f90-163d-0bdd-1099-55d18a900e68phentermine 3.75 MG / topiramate 23 MG 24HR Extended Release Oral CapsulePSN9These highlights do not include all the information needed to use PHENTERMINE AND TOPIRAMATE EXTENDED-RELEASE CAPSULES, safely and effectively. See full prescribing information for PHENTERMINE AND TOPIRAMATE EXTENDED-RELEASE CAPSULES. PHENTERMINE and TOPIRAMATE extended-release capsules, for oral use, CIV Initial U.S. Approval: 201220260331
918df93d-e033-4419-adcc-e21655ef815824 HR phentermine 3.75 MG / topiramate 23 MG Extended Release Oral CapsuleSCD6These highlights do not include all the information needed to use PHENTERMINE AND TOPIRAMATE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for PHENTERMINE AND TOPIRAMATE EXTENDED-RELEASE CAPSULES . PHENTERMINE and TOPIRAMATE extended-release capsules, for oral use, CIV Initial U.S. Approval: 201220260330
918df93d-e033-4419-adcc-e21655ef8158phentermine 3.75 MG / topiramate 23 MG 24 HR Extended Release Oral CapsuleSY6These highlights do not include all the information needed to use PHENTERMINE AND TOPIRAMATE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for PHENTERMINE AND TOPIRAMATE EXTENDED-RELEASE CAPSULES . PHENTERMINE and TOPIRAMATE extended-release capsules, for oral use, CIV Initial U.S. Approval: 201220260330
918df93d-e033-4419-adcc-e21655ef8158phentermine 3.75 MG / topiramate 23 MG 24HR Extended Release Oral CapsulePSN6These highlights do not include all the information needed to use PHENTERMINE AND TOPIRAMATE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for PHENTERMINE AND TOPIRAMATE EXTENDED-RELEASE CAPSULES . PHENTERMINE and TOPIRAMATE extended-release capsules, for oral use, CIV Initial U.S. Approval: 201220260330
876bd763-13fa-481e-b579-c2fc44dbf3c224 HR phentermine 3.75 MG / topiramate 23 MG Extended Release Oral CapsuleSCD4These highlights do not include all the information needed to use PHENTERMINE AND TOPIRAMATE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for PHENTERMINE AND TOPIRAMATE EXTENDED-RELEASE CAPSULES. Phentermine and Topiramate Extended-Release Capsules, for oral use, CIV Initial U.S. Approval: 201220260518
876bd763-13fa-481e-b579-c2fc44dbf3c2phentermine 3.75 MG / topiramate 23 MG 24HR Extended Release Oral CapsulePSN4These highlights do not include all the information needed to use PHENTERMINE AND TOPIRAMATE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for PHENTERMINE AND TOPIRAMATE EXTENDED-RELEASE CAPSULES. Phentermine and Topiramate Extended-Release Capsules, for oral use, CIV Initial U.S. Approval: 201220260518
876bd763-13fa-481e-b579-c2fc44dbf3c2phentermine 3.75 MG / topiramate 23 MG 24 HR Extended Release Oral CapsuleSY4These highlights do not include all the information needed to use PHENTERMINE AND TOPIRAMATE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for PHENTERMINE AND TOPIRAMATE EXTENDED-RELEASE CAPSULES. Phentermine and Topiramate Extended-Release Capsules, for oral use, CIV Initial U.S. Approval: 201220260518